Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo. - Shuai H; Qiao J; Yoon C; Zhang G; Hou Y; Xia X; Wang L; Deng X; Wang Y; Li Q; Du L; Liu Y; et al. (Nature communications, 2025)